What Does Genentech Do?

Total employees17799
HeadquartersSouth San Francisco
Founded1976

Genentech is a leading biotechnology company that discovers, develops, manufactures, and commercializes medicines to treat patients with serious and life-threatening medical conditions. As a member of the Roche Group, Genentech has been at the forefront of the biotechnology industry for over 40 years, using human genetic information to develop novel medicines. The company is known for its strong scientific foundation, innovative research, and commitment to transforming patient care in areas such as oncology, immunology, neuroscience, and ophthalmology.

Where Is Genentech's Headquarters?

HQ Function

Serves as the primary center for research, development, corporate operations, and U.S. commercial activities.

Notable Features:

Sprawling, modern campus with state-of-the-art research laboratories, collaborative workspaces, advanced manufacturing capabilities, and employee amenities reflecting its focus on innovation and well-being.

Work Culture:

Highly innovative, science-driven, collaborative, and mission-focused, emphasizing breakthrough research and patient impact. Strong emphasis on diversity, inclusion, and employee development.

HQ Significance:

Considered the birthplace of the biotechnology industry. It remains a major hub for R&D within the Roche Group and a significant contributor to the San Francisco Bay Area's life sciences ecosystem.

Values Reflected in HQ: The campus design and facilities reflect Genentech's core values of innovation (advanced labs), collaboration (open and shared workspaces), patient-focus (mission-driven environment), and sustainability (various green initiatives and eco-friendly building designs).

Location:

While Genentech's primary operations are in the United States, as a member of the Roche Group, its innovations and medicines reach patients globally. Genentech supports global functions through its world-class research and early development (gRED) and product development capabilities based in South San Francisco. Its U.S. manufacturing sites in California and Oregon contribute to Roche's global supply chain. Commercialization outside the U.S. is typically handled by Roche's global network, ensuring that Genentech's discoveries benefit patients worldwide.

Street Address:

1 DNA Way

City:

South San Francisco

State/Province:

California

Country:

USA

Where Else Does Genentech Operate Around the World?

Hillsboro, Oregon, USA

Address: 1 Antibody Way, Hillsboro, OR 97124, USA

Supports large-scale production of therapeutics for the U.S. and global markets, playing a key role in the company's supply chain and manufacturing excellence.

Vacaville, California, USA

Address: 1000 New Horizons Way, Vacaville, CA 95688, USA

Ensures large-scale, reliable supply of critical medicines for patients worldwide, representing a significant manufacturing capacity for the Roche Group.

Oceanside, California, USA

Address: 1 Genentech Way, Oceanside, CA 92056, USA

Contributes to Genentech's diverse manufacturing network, ensuring production capabilities for various product types and supporting both clinical trial and commercial supply needs.

Buying Intent Signals for Genentech

Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.

Notable news
Hiring actively
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
*Example signal, not calculated in real time

Who's Leading Genentech? Meet the Executive Team

As of April 2025, Genentech' leadership includes:

Alexander Hardy - Chief Executive Officer
Ravi Abrol - Head of Genentech Research and Early Development (gRED)
Ashley Magargee - Chief Operating Officer
Corsee Sanders, Ph.D. - Global Head of Clinical Operations, Roche and Genentech
Fritz Bittenbender - Head of U.S. Government Affairs, Roche and Genentech
Jennifer Lin - Head of U.S. Human Resources

Who's Investing in Genentech?

Genentech has been backed by several prominent investors over the years, including:

Roche Holding AG (Genentech is a wholly-owned member of the Roche Group)

What Leadership Changes Has Genentech Seen Recently?

Hire1
Exits0

Genentech's executive team saw a key leadership appointment in the last 12 months with the naming of a new Head of gRED. Overall, the top leadership structure aims for stability combined with strategic enhancements to drive its mission.

New Appointments:

Ravi Abrol, Ravi Abrol appointed as Head of gRED, responsible for overseeing the company's research pipeline and early-stage clinical development.

What Technology (Tech Stack) Is Used byGenentech?

Discover the tools Genentech uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.

Genentech Email Formats and Examples

Genentech commonly uses specific email formats for its employees. The most frequently observed patterns are [lastname][firstinitial]@gene.com or [firstname].[lastname]@gene.com. These formats allow for systematic communication within the organization and with external partners.

lastnamef@gene.com or firstname.lastname@gene.com

Format

doej@gene.com or jane.doe@gene.com

Example

85%

Success rate

What's the Latest News About Genentech?

Genentech Press ReleaseMay 20, 2024

Genentech’s Crovalimab Shows Robust Efficacy and Safety in Children and Adolescents With Paroxysmal Nocturnal Hemoglobinuria, a Life-Threatening Blood Disorder

New Phase III data presented at the 2024 European Hematology Association Congress show subcutaneous crovalimab was well-tolerated and effectively controlled disease in children and adolescents with PNH....more

Genentech Press ReleaseFebruary 16, 2024

Genentech Announces FDA Approval of XOLAIR® (omalizumab) for Children and Adults with Food Allergy

XOLAIR is the first and only FDA-approved medicine to reduce allergic reactions to multiple foods after accidental exposure. This approval marks a significant advancement for people living with food allergies....more

Genentech Press ReleaseFebruary 3, 2024

Genentech’s Vabysmo Shows Strong, Sustained Efficacy in New Long-Term Data for Retinal Vein Occlusion

New data presented at Angiogenesis, Exudation, and Degeneration 2024 showed Vabysmo continues to demonstrate robust vision gains and drying of retinal fluid in RVO, with extended dosing intervals up to every four months for eligible patients....more

Highperformr's free tools for company research

Explore Employees by Region or Country

See where a company’s workforce is located, by country or region.

View Funding Details

View past and recent funding rounds with amounts and investors.

Understand Revenue Insights

Understand company revenue estimates and financial scale.

Track Active Job Openings

Track active roles and hiring trends to spot growth signals.

Review Product and Offerings

Discover what a company offers—products, platforms, and solutions.

Get SIC or NAICS Codes

Get the company’s official SIC and NAICS classifications.

Analyze Website Traffic Trends

Analyze visitor volume, engagement, and top traffic sources.

Discover Social Profiles and Engagement

Explore LinkedIn, Twitter, and other active social profiles.

Identify Top Competitors

Identify top competitors based on similar business traits.

Research and Discover Companies with Highperformr — Smarter, Faster

Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.

Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.

  • Track intent signals to find buyers who are actively in-market
  • Enrich contacts and companies instantly, no need to switch tools
  • Automate workflows to stay ahead of every change
  • Connect your CRM & tools for seamless data sync and activation

Thousands of companies, including Genentech, are just a search away.